dc.creatorMonteiro-Dantas C.
dc.creatorEspejo-Arce X.
dc.creatorLui-Filho J.F.
dc.creatorFernandes A.M.
dc.creatorMonteiro I.
dc.creatorBahamondes L.
dc.date2007
dc.date2015-06-30T18:52:36Z
dc.date2015-11-26T14:39:10Z
dc.date2015-06-30T18:52:36Z
dc.date2015-11-26T14:39:10Z
dc.date.accessioned2018-03-28T21:44:41Z
dc.date.available2018-03-28T21:44:41Z
dc.identifier
dc.identifierReproductive Health. , v. 4, n. , p. - , 2007.
dc.identifier17424755
dc.identifier10.1186/1742-4755-4-11
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-38349070947&partnerID=40&md5=e6049aa0d6d3580c793fa42810fd193a
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/105200
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/105200
dc.identifier2-s2.0-38349070947
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1249887
dc.descriptionBackground. The aim of this study was to evaluate bone mineral density (BMD) at baseline and at 18 and 36 months of use of etonogestrel (ENG)-and levonorgestrel (LNG)-releasing contraceptive implants. This is a continuation of a previous study in which BMD was evaluated at baseline and at 18 months of use. Methods. A total of 111 women, 19-43 years of age, wererandomly allocated to use one of the two implants. At 36 months of follow-up, only 36 and 39 women were still using the ENG- and LNG-releasing implants, respectively. BMD was evaluated at the distal and at the ultra-distal radius of the non-dominant forearm using dual-energy X-ray absorptiometry. Results. There was no difference in the BMD of users of either implant at 18 and at 36 months. BMD was significantly lower at 18 and at 36 months at the distal radius in both groups of users compared to pre-insertion values; however, no difference was found at the ultra-distal radius. Conclusion. Women 19-43 years of age using either one of these two contraceptive implants for 36 months had lower BMD values at the distal radius compared to pre-insertion values; however, no difference was found at the ultra-distal radius. © 2007 Monteiro-Dantas et al; licensee BioMed Central Ltd.
dc.description4
dc.description
dc.description
dc.description
dc.descriptionCurtis, K.M., Martins, S.L., Progestogen-only contraception and bone mineral density: A systematic review (2006) Contraception, 73, pp. 470-487. , 10.1016/j.contraception.2005.12.010. 16627031
dc.descriptionRiggs, B.L., Melton, L.J., Involutional osteoporosis (1986) N Engl J Med, 314, pp. 1676-1686. , 3520321
dc.descriptionRecker, R.R., Davies, K.M., Hinders, S.M., Heaney, R.P., Stegman, M.R., Kimmel, D.B., Bone gain in young adult women (1992) JAMA, 268, pp. 2403-2408. , 10.1001/jama.268.17.2403. 1404797
dc.descriptionGbolade, B., Ellis, S., Murby, B., Randall, S., Kirkman, R., Bone density in long-term users of depot medroxyprogesterone acetate (1998) Br J Obstet Gynaecol, 105, pp. 790-794. , 9692421
dc.descriptionBahamondes, L., Trevisan, M., Andrade, L., Marchi, N.M., Castro, S., Faundes, A., The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera (2000) Contraception, 62, pp. 23-27. , 10.1016/S0010-7824(00)00132-3. 11024225
dc.descriptionCundy, T., Evans, M., Roberts, H., Wattie, D., Ames, R., Reid, I.R., Bone density in women receiving depot medroxyprogesterone acetate for contraception (1991) BMJ, 303, pp. 13-16. , 1830502
dc.descriptionTang, O.S., Tang, G., Yip, P., Li, B., Fan, S., Long-term depot-medroxyprogesterone acetate and bone mineral density (1999) Contraception, 59, pp. 25-29. , 10.1016/S0010-7824(98)00144-9. 10342083
dc.descriptionPetitti, D.B., Piaggio, G., Mehta, S., Cravioto, M.C., Meirik, O., Steroid hormone contraception and bone mineral density: A cross-sectional study in an international population. the WHO Study of Hormonal Contraception and Bone Health (2000) Obstet Gynecol, 95, pp. 736-744. , 10.1016/S0029-7844(00)00782-1. 10775740
dc.descriptionStates Food, U., Administration, D., Talk Paper Black Box Warning Added Concerning Long-Term Use of Depo-Provera Contraceptive Injection, , November 17, 2004
dc.descriptionDuff, G., Updated Prescribing Advice on the Effect of Depo-Provera Contraception on Bones HSS, , http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&dDocName= con019478&RevisionSelectionMethod=Latest, (MD) 39-2004, November, 19, 2004
dc.descriptionD'Arcangues, C., WHO statement on hormonal contraception and bone health (2006) Contraception, 73, pp. 443-444. , 10.1016/j.contraception.2006.01.002. 16627029
dc.descriptionTaneepanichskul, S., Intaraprasert, S., Theppisai, U., Chaturachinda, K., Bone mineral density during long-term treatment with Norplant implants and depot medroxyprogesterone acetate. a cross-sectional study of Thai women (1997) Contraception, 56, pp. 153-155. , 10.1016/S0010-7824(97)00116-9. 9347205
dc.descriptionDi, X., Li, Y., Zhang, C., Jiang, J., Gu, S., Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism (1999) Contraception, 60, pp. 161-166. , 10.1016/S0010-7824(99)00080-3. 10640160
dc.descriptionBeerthuizen, R., Van Beek, A., Massai, R., Makarainen, L., Hout, J., Bennink, H.C., Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception (2000) Hum Reprod, 15, pp. 118-122. , 10.1093/humrep/15.1.118. 10611199
dc.descriptionBahamondes, L., Monteiro-Dantas, C., Espejo-Arce, X., Dos Santos Fernandes, A.M., Lui-Filho, J.F., Perrotti, M., Petta, C.A., A prospective study of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants (2006) Hum Reprod, 21, pp. 466-470. , 10.1093/humrep/dei358. 16253974
dc.descriptionPocock, S.J., (1987) Clinical Trials: A Practical Approach, , Chichester: John Wiley and Sons
dc.descriptionKanis, J.A., Johnell, O., Oden, A., Johansson, H., De Laet, C., Eisman, J.A., Fujiwara, S., Tenenhouse, A., Smoking and fracture risk: A meta-analysis (2005) Osteoporos Int, 16, pp. 155-62. , 10.1007/s00198-004-1640-3. 15175845
dc.descriptionKanis, J.A., Johansson, H., Johnell, O., Oden, A., De Laet, C., Eisman, J.A., Pols, H., Tenenhouse, A., Alcohol intake as a risk factor for fracture (2005) Osteoporos Int, 16, pp. 737-742. , 10.1007/s00198-004-1734-y. 15455194
dc.descriptionArmitage, P., (1991) Statistical Methods in Medical Research, , New York: A Halsted Press Book, John Wiley and Sons
dc.descriptionHealth Organization, W., Assessment of Fracture Risk and its Application to Screening for Post-menopausal Osteoporosis: Report of a WHO Study Group (1994) WHO, Geneva (WHO Technical Report Series 843)
dc.descriptionCroxatto, H.B., Urbancsek, J., Massai, R., Coelingh Bennink, H., Van Beek, A., A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group (1999) Hum Reprod, 14, pp. 976-981. , 10.1093/humrep/14.4.976. 10221230
dc.descriptionCroxatto, H.B., Makarainen, L., The pharmacodynamics and efficacy of Implanon. An overview of the data (1998) Contraception, 58 (SUPPL.), pp. 91-97. , 10.1016/S0010-7824(98)00118-8
dc.descriptionCroxatto, H.B., Diaz, S., Pavez, M., Brandeis, A., Estradiol plasma levels during long-term treatment with Norplant subdermal implants (1988) Contraception, 38, pp. 465-475. , 10.1016/0010-7824(88)90087-X. 3145171
dc.descriptionCroxatto, H.B., Progestin implants (2000) Steroids, 65, pp. 681-685. , 10.1016/S0039-128X(00)00124-0. 11108876
dc.descriptionDiaz, S., Reyes, M.V., Zepeda, A., Gonzalez, G.B., Lopez, J.M., Campino, C., Croxatto, H.B., Norplant implants and progesterone vaginal rings do not affect maternal bone turnover and density during lactation and after weaning (1999) Hum Reprod, 14, pp. 2499-2505. , 10.1093/humrep/14.10.2499. 10527977
dc.descriptionNaessen, T., Olsson, S.E., Gudmundson, J., Differential effects on bone density of progestogen-only methods for contraception in premenopausal women (1995) Contraception, 52, pp. 35-39. , 10.1016/0010-7824(95)00121-P. 8521712
dc.descriptionCromer, B.A., Blair, J.M., Mahan, J.D., Zibners, L., Naumovski, Z., A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo Provera), levonorgestrel (Norplant), or oral contraceptives (1996) J Pediatr, 129, pp. 671-676. , 10.1016/S0022-3476(96)70148-8. 8917232
dc.descriptionMarshall, D., Johnell, O., Wedel, H., Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures (1996) BMJ, 312, pp. 1254-1259. , 8634613
dc.descriptionSiris, E.S., Miller, P.D., Barrett-Connor, E., Faulkner, K.G., Wehren, L.E., Abbott, T.A., Berger, M.L., Sherwood, L.M., Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: Results from the National Osteoporosis Risk Assessment (2001) JAMA, 286, pp. 2815-2822. , 10.1001/jama.286.22.2815. 11735756
dc.descriptionLopez, L.M., Grimes, D.A., Schulz, K.F., Curtis, K.M., Steroidal contraceptives: Effect on bone fractures in women (2006) Cochrane Database Syst Rev, (4), p. 006033. , 17054270
dc.descriptionCummings, S.R., Bates, D., Black, D.M., Clinical use of bone densitometry: Scientific review (2002) JAMA, 288, pp. 1889-97. , 10.1001/jama.288.15.1889. 12377088
dc.descriptionOrr-Walker, B.J., Evans, M.C., Ames, R.W., Clearwater, J.M., Cundy, T., Reid, I.R., The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women (1998) Clin Endocrinol (Oxf), 49, pp. 615-618. , 10.1046/j.1365-2265.1998.00582.x. 10197077
dc.descriptionCefalu, C.A., Is bone mineral density predictive of fracture risk reduction? (2004) Curr Med Res Opin, 20, pp. 341-349. , 10.1185/030079903125003062. 15025843
dc.languageen
dc.publisher
dc.relationReproductive Health
dc.rightsaberto
dc.sourceScopus
dc.titleA Three-year Longitudinal Evaluation Of The Forearm Bone Density Of Users Of Etonogestrel- And Levonorgestrel-releasing Contraceptive Implants
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución